Altimmune Stock

Altimmune Book Value per Share

The Book Value per Share of Altimmune (ALT) as of Sep 14, 2026 is 3.17 USD. In the previous year, Book Value per Share was 1.74 USD — a change of 82.09% (higher).

Book Value per Share

3.17USD

YoY

82.09%

Last updated:

Book Value per Share of Altimmune is 2026 3.17 USD. Book Value per Share of Altimmune was 2025 1.74 USD. It decreases by 82.09% higher compared to the previous year.

The Altimmune Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
0.68 USD
Jan 1, 2019
0.64 USD
Jan 1, 2020
3.18 USD
Jan 1, 2021
2.80 USD
Jan 1, 2022
2.61 USD
Jan 1, 2023
2.73 USD
Jan 1, 2024
1.74 USD
Jan 1, 2025
3.17 USD
The Altimmune Book Value per Share history
YEARBook Value per ShareYoY
3.17USD+82.09%
1.74USD-36.37%
2.73USD+4.75%
2.61USD-6.95%
2.80USD-11.84%
3.18USD+396.21%
0.64USD-5.78%
0.68USD-0.75%
0.69USD+150.15%
0.27USD+16.88%
0.23USD-8.89%
0.26USD—
Access this data via the Eulerpool API
Get Free API Key

Altimmune Stock analysis

What does Altimmune do? Altimmune Inc is a biopharmaceutical company specializing in the development of immunotherapies. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland, USA. Altimmune is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Altimmune stock

Book Value per Share of Altimmune is 3.17 USD in 2026.

Book Value per Share of Altimmune changed from 1.74 USD to 3.17 USD, representing a 82.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Altimmune since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Altimmune

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Altimmune